Clinical Trials Directory

Trials / Completed

CompletedNCT02337569

A Randomized, Double-Blind, Placebo Controlled Study of NPC-02 in Patients With Zinc Deficiency

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
57 (actual)
Sponsor
Nobelpharma · Industry
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to evaluate efficacy and safety of NPC-02 in patients with Zinc Deficiency.

Conditions

Interventions

TypeNameDescription
DRUGNPC-02
DRUGPlacebos

Timeline

Start date
2015-01-01
Primary completion
2015-11-01
Completion
2015-11-01
First posted
2015-01-13
Last updated
2019-04-17

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT02337569. Inclusion in this directory is not an endorsement.

A Randomized, Double-Blind, Placebo Controlled Study of NPC-02 in Patients With Zinc Deficiency (NCT02337569) · Clinical Trials Directory